Predicted protein targets (top 7)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ACE | P12821 | 5/20 | 0.48 |
| ▸ | REN | P00797 | 2/20 | 0.46 |
| ▸ | DPP4 | P27487 | 2/20 | 0.45 |
| ▸ | DPP8 | Q6V1X1 | 2/20 | 0.45 |
| ▸ | DPP9 | Q86TI2 | 2/20 | 0.45 |
| ▸ | DPP7 | Q9UHL4 | 2/20 | 0.45 |
| ▸ | FAP | Q12884 | 1/20 | 0.45 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL29609766 | 0.96 | ACE (0.51) | ACERENDPP4DPP8DPP9 | |
| SCHEMBL30817477 | 0.94 | ACE (0.49) | ACERENDPP4DPP8DPP9 | |
| SCHEMBL30423512 | 0.94 | ACE (0.49) | ACERENDPP4DPP8DPP9 | |
| SCHEMBL29801964 | 0.92 | ACE (0.48) | ACERENDPP4DPP8DPP9 | |
| SCHEMBL29802076 | 0.91 | ACE (0.51) | ACEREN | |
| SCHEMBL29802092 | 0.90 | NTSR2 (0.43) | ACEDPP4DPP8DPP9DPP7 | |
| SCHEMBL29801880 | 0.89 | ACE (0.50) | ACEREN | |
| SCHEMBL29801966 | 0.88 | ACE (0.51) | ACE | |
| SCHEMBL29801988 | 0.88 | ACE (0.51) | ACE | |
| SCHEMBL31665888 | 0.87 | NTSR2 (0.45) | — |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-4306534-A1 | MULTIFUNCTIONAL POLYPEPTIDE AND APPLICATION THEREOF IN FIELD OF MEDICINES | Wuhan Innerse Pharmaceutical Inc. (CN) | 2024-01-17 | — | — | EP | disclosed |
| WO-2022188878-A1 | MULTIFUNCTIONAL POLYPEPTIDE AND APPLICATION THEREOF IN FIELD OF MEDICINES | 武汉英纳氏药业有限公司 | 2022-09-15 | — | — | WO | disclosed |